Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Kirsty (insulin aspart-xjhz), an Interchangeable Biosimilar to NovoLog

BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India: July 15, 2025 -- Biocon Biologics Ltd (BBL), a fully integrated global...

U.S. FDA Approves Kerendia (finerenone) to Treat Patients with Heart Failure with Left Ventricular Ejection Fraction ≥40% Following Priority Review

WHIPPANY, N.J., July 14, 2025 – Bayer today announced that the U.S. Food and Drug Administration (FDA) approved Kerendia (finerenone) to treat patients...

Fewer Opioids Being Prescribed for Low Back Pain in the Emergency Department

From 2016 to 2022, 5.3 percent of all U.S. emergency department visits were related to low back pain, with opioid administration and prescription decreasing...

ENDO: AI Model Integrated Into Retina Tracker IDs Diabetic Retinopathy

An artificial intelligence (AI) model integrated into a retina tracker for diabetic retinopathy can achieve high accuracy while being resource-efficient,...

ENDO: Primary Aldosteronism Screening Recommended for All With Hypertension

All individuals with hypertension should be screened for primary aldosteronism (PA), according to a clinical practice guideline issued by the Endocrine...

Specific Antiseizure Medications Associated With Major Malformations in Infants

Maternal use of valproate, phenobarbital, and topiramate early in pregnancy is associated with an increased risk for major malformations in infants compared...

8 Babies Born Using New IVF Technique to Prevent Rare Genetic Diseases

FRIDAY, July 18, 2025 — A new IVF technique helped eight babies in the U.K. avoid serious inherited diseases, and scientists are calling it a breakthrough. All...

Trump Diagnosed With Common Vein Condition in the Legs

FRIDAY, July 18, 2025 — President Donald Trump has been diagnosed with a vein condition that affects many older adults, the White House said. Trump,...

FDA Approves Juul E-Cigs for Sale, Years After Ban Attempt

FRIDAY, July 18, 2025 — After years of legal battles and health concerns, Juul Labs has the go-ahead to sell some of its electronic cigarettes in...

Hispanic People Have Unexplained Higher Risk For Nerve Disorder

FRIDAY, July 18, 2025 — Hispanic people are more likely to develop peripheral neuropathy than white people, and it’s not clear why, a new study...

Update on CARES Phase III Clinical Programme of Anselamimab in Light Chain Amyloidosis

High-level results from the Cardiac Amyloid Reaching for Extended Survival (CARES) Phase III clinical programme showed that anselamimab, a light chain...

Doctors Overlooking Common Cause Of High Blood Pressure, New Guidelines Say

WEDNESDAY, July 16, 2025 — Doctors are regularly overlooking a common hormone-driven cause of high blood pressure, a new paper warns. As many as...

FDA Issues Warning Letters to Firms Marketing Products Containing 7-Hydroxymitragynine

The U.S. Food and Drug Administration today announced seven recent warning letters sent to companies for illegally marketing products containing 7-hydroxymitragynine,...

Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in Microsatellite Stable Colorectal Cancer Following Productive Type B (End of Phase 1) Meeting with FDA

SAN DIEGO and SUZHOU, China, July 15, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene or the Company”) (Nasdaq:...

Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Cefazolin for Injection Due to Product Mispackaging

UPDATE July 14, 2025 – Sandoz, Inc. (“Sandoz”) is initiating a voluntary nationwide recall expansion of one additional lot of Cefazolin...

Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer

(BUSINESS WIRE)--Jul. 14, 2025-- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development...

Read more news...

Recently Added

Recently added consumer and prescribing information: Zegfrovy, Lynozyfic, Arynta, Harliku, Ibtrozi, Miudella, Opdivo Qvantig, Alyftrek, Crenessity, Ensacove

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Kirsty Kirsty (insulin aspart-xjhz) is a rapid acting human insulin analog interchangeable biosimilar to NovoLog (insulin aspart) indicated to...
  • Ekterly Ekterly (sebetralstat) is an oral plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema attacks in adults and...
  • Lynozyfic Lynozyfic (linvoseltamab-gcpt) is a bispecific B-cell maturation antigen (BCMA)‑directed CD3 T-cell engager for the treatment of relapsed o...

More FDA approvals